However, the response of patients with NSCLC harboring HIP1-ALK to ALK inhibitors and potential resistance mechanisms to such remain unknown.     ///    "To date, two variants of HIP1-ALK (H21. "    ///    Identification of a novel HIP1-ALK fusion variant in Non-Small-Cell Lung Cancer (NSCLC) and discovery of ALK I1171 (I1171N/S) mutations in two ALK-rearranged NSCLC patients with resistance to Alectinib..     ///    "Here, we report a patient with NSCLC harboring a novel HIP1-ALK fusion variant (H30. "    ///    "Here, we report a patient with NSCLC harboring a novel HIP1-ALK fusion variant (H30; A20)."